Inventor · disambiguated record
Jens Nagel
Also filed as: NAGEL JENS
17 granted patents·8 pending applications·28 citations·filing 2007–2023
90Inventor score
Top patents by PatentIndex Score
25 records- 0190US10202369B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2017·Granted Feb 12, 2019·4 cites·26 claims
- 0289US10472354B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2018·Granted Nov 12, 2019·3 cites·13 claims
- 0389US10174016B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2015·Granted Jan 8, 2019·4 cites·34 claims
- 0486US11142523B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2019·Granted Oct 12, 2021·2 cites·16 claims
- 0581US10183937B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2017·Granted Jan 22, 2019·4 cites·22 claims
- 0680US7985753B2Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulatorsMERZ PHARMA GMBH & CO KGAA·Filed 2007·Granted Jul 26, 2011·6 cites·19 claims
- 0773US2023053411A11,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2021·Application pending·0 cites
- 0872US11905270B2Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptorBayer Pharma AG·Filed 2017·Granted Feb 20, 2024·1 cites·3 claims
- 0971US9708311B2Benzimidazole derivatives as EP4 antagonistsBayer Pharma AG·Filed 2013·Granted Jul 18, 2017·2 cites·10 claims
- 1069US7947689B2Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modulatorsMERZ PHARMA GMBH & CO KGAA·Filed 2007·Granted May 24, 2011·1 cites·19 claims
- 1168US12239630B2Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptorBayer Pharma AG·Filed 2023·Granted Mar 4, 2025·0 cites·3 claims
- 1266US12023319B2Carboxylic acid aromatic amidesBayer Pharma AG·Filed 2021·Granted Jul 2, 2024·0 cites·5 claims
- 1357US8288549B2Glycine B antagonistHENRICH MARKUS·Filed 2009·Granted Oct 16, 2012·1 cites·12 claims
- 1454US2023270729A1Use of n-phenylacetamides having p2x4 receptor antagonistic activity for treating certian ocular disordersBAYER AG·Filed 2021·Application pending·0 cites
- 1551US2023257351A1Substituted n-phenylacetamides having p2x4 receptor antagonistic activityBAYER AG·Filed 2021·Application pending·0 cites
- 1648US2011003820A1Pyrazolopyrimidines, a process for their preparation and their use as medicineMERZ PHARMA GMBH & CO KGAA·Filed 2009·Application pending·0 cites
- 1747US2011212956A1Pyrazolopyrimidines for treating CNS disordersMERZ PHARMA GMBH & CO KGAA·Filed 2011·Application pending·0 cites
- 1846US10730856B2Benzimidazole derivatives as EP4 ligandsBayer Pharma AG·Filed 2014·Granted Aug 4, 2020·0 cites·9 claims
- 1940US11319324B2Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitorsBAYER AG·Filed 2018·Granted May 3, 2022·0 cites·11 claims
- 2040US2019177279A1Carboxylic acid aromatic 1,2-cyclopropylamidesBayer Pharma AG·Filed 2018·Application pending·0 cites
- 2139US11136296B2Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereofBAYER AG·Filed 2018·Granted Oct 5, 2021·0 cites·13 claims
- 2238US11149018B2Substituted N-arylethyl-2-aminoquinoline-4-carboxamides and use thereofBAYER AG·Filed 2018·Granted Oct 19, 2021·0 cites·12 claims
- 2338US10172814B2Substituted pyridyl-cycloalkyl-carboxylic acids, compositions containing them and medical uses thereofBayer Pharma AG·Filed 2015·Granted Jan 8, 2019·0 cites·21 claims
- 2438US2021317092A1Tetrazole containing compoundsBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2524US2012220577A1Glycine b antagonistsHENRICH MARKUS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jens Nagel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →